Thousands who suffer heart attacks each year die before reaching a hospital or clinic where they can benefit from the drugs that dissolve clots in coronary arteries. The Food and Drug Administration recently approved a new blood clot dissolving agent, which a spokesman claimed could save the lives of many people who would otherwise join this group of heart attack victims.
Which of the following, if true, would seriously weaken the argument above?
(A) The new agent must be administered by a team of doctors in a hospital or clinic setting.
(B) Many heart attack victims die unnecessarily even though they reach a hospital or clinic in time
(C) The new agent can be effectively administered prior to the victim's arrival at a hospital or clinic
(D) The Food and Drug Administration has already approved agents that are at least as effective as the new drug in dissolving blood clots
(E) The new blood clot dissolving agent causes kidney damage and irregular heart rates in some patients.
Please explain to me why is it the best Option? What is wrong with the other Options?
OA A
Which of the following, if true, would seriously weaken the argument above?
(A) The new agent must be administered by a team of doctors in a hospital or clinic setting.
(B) Many heart attack victims die unnecessarily even though they reach a hospital or clinic in time
(C) The new agent can be effectively administered prior to the victim's arrival at a hospital or clinic
(D) The Food and Drug Administration has already approved agents that are at least as effective as the new drug in dissolving blood clots
(E) The new blood clot dissolving agent causes kidney damage and irregular heart rates in some patients.
Please explain to me why is it the best Option? What is wrong with the other Options?
OA A
